Li Bingjie, Xu Lixiu, Chen Chu, Ye Jiqing
School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China.
ACS Omega. 2024 Nov 23;9(49):48657-48669. doi: 10.1021/acsomega.4c07757. eCollection 2024 Dec 10.
V-domain immunoglobulin suppressor of T cell activation (VISTA), an inhibitory immune checkpoint present on both immune and tumor cells, has emerged as a highly promising target for cancer therapy due to its potential to overcome resistance encountered with existing immune checkpoint treatments. VSIG-3 is determined as an inhibitory ligand for VISTA, leading to the suppression of T cell proliferation. However, hotspots between VISTA/VSIG-3 protein-protein interaction remain ambiguous, mainly attributed to the lack of the structure of the VISTA/VSIG-3 complex. Therefore, in this study, in order to determine the energetic contributions of the interfacial residues on VISTA, we first constructed VISTA/VSIG-3 complex models by the protein docking method, followed by molecular dynamics simulations, binding free-energy decomposition, and alanine scanning. Results suggested that the putative hotspots in VISTA comprise residues His32, Tyr37, Thr35, Glu47, Val48, Gln49, Glu53, Arg54, Gln73, His122, and His126. Moreover, the distribution of the hotspots was clustered into two regions (hot regions I and II), and by using the TRAPP tool, transient subpockets within the hot regions were identified. Furthermore, conformational states of the binding pockets exhibiting druggability scores higher than those observed in the crystal structure were found. Overall, we hope that the findings outlined in this study can be used to facilitate the development of inhibitors targeting the VISTA/VSIG-3 immune checkpoint pathway in the future.
T细胞活化V结构域免疫球蛋白抑制因子(VISTA)是一种存在于免疫细胞和肿瘤细胞上的抑制性免疫检查点,由于其有潜力克服现有免疫检查点治疗中遇到的耐药性,已成为癌症治疗中极具前景的靶点。VSIG-3被确定为VISTA的抑制性配体,可导致T细胞增殖受到抑制。然而,VISTA/VSIG-3蛋白-蛋白相互作用的热点仍不明确,主要原因是缺乏VISTA/VSIG-3复合物的结构。因此,在本研究中,为了确定VISTA上界面残基的能量贡献,我们首先通过蛋白质对接方法构建了VISTA/VSIG-3复合物模型,随后进行分子动力学模拟、结合自由能分解和丙氨酸扫描。结果表明,VISTA中假定的热点包括His32、Tyr37、Thr35、Glu47、Val48、Gln49、Glu53、Arg54、Gln73、His122和His126等残基。此外,这些热点分布聚集成两个区域(热点区域I和II),并使用TRAPP工具在热点区域内识别出瞬时亚口袋。此外,还发现了结合口袋的构象状态,其可成药分数高于晶体结构中的观察值。总体而言,我们希望本研究中概述的发现可用于促进未来针对VISTA/VSIG-3免疫检查点途径的抑制剂的开发。